Stevanato Group (87N) Price & Analysis

3 Followers

87N Stock Chart & Stats

€18.20

€0.20(1.18%)

At close: Jul 24 4:00 PM EDT

€18.20

€0.20(1.18%)

Day’s Range― - ―

52-Week Range€11.30 - €23.60

Previous CloseN/A

Volume0.00

Average Volume (3M)0.00

Market Cap

€4.74B

Enterprise Value€5.35B

Total Cash (Recent Filing)€83.58M

Total Debt (Recent Filing)€442.99M

Price to Earnings (P/E)36.2

Beta0.40

Next Earnings

Nov 03, 2026

EPS Estimate

0.16

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.48

Shares Outstanding49,709,717

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio2.50

Price to Book (P/B)3.15

Price to Sales (P/S)4.10

P/FCF Ratio218.04

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€20.71

Price Target Upside13.79% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering7

EPS Forecast (FY)0.54

Revenue Forecast (FY)€1.13B

Bulls Say, Bears Say

Bulls Say

High-Value Solutions GrowthRapid growth in high-value solutions is improving Stevanato’s revenue mix toward biologics and premium products. A larger share of differentiated offerings can support stronger profitability, deepen customer integration, and reinforce the company’s position across drug containment and delivery markets.

Profitability And Margin ExpansionThe combination of faster EBITDA growth and substantial margin expansion indicates improving operating leverage and execution. If supported by the company’s higher-value mix and ongoing projects, this can strengthen earnings quality and provide more internal capacity to fund strategic growth.

Conservative Balance SheetModerate leverage and a substantial equity base give Stevanato financial resilience while it expands production capacity and develops delivery platforms. This capitalization reduces balance-sheet strain relative to a highly leveraged structure and preserves flexibility for investment over the coming quarters.

Bears Say

Weak Free-Cash-Flow ConversionPositive operating cash flow is not currently translating consistently into free cash flow because capital spending and working-capital needs absorb cash. Continued weak conversion could constrain financial flexibility, especially while multiple capacity projects require substantial ongoing investment.

Engineering Revenue And Sales-Cycle RiskEngineering’s revenue decline and elongated sales cycles create a less predictable contribution from a strategically important business line. Even with improved margins, delayed orders or project timing can postpone growth, reduce operating leverage, and complicate execution against consolidated targets.

Cost And Tax HeadwindsHigher depreciation, utilities, and taxes can limit how much of the company’s operational improvement reaches net earnings and cash generation. These pressures may persist as new plants and capacity investments ramp, making sustained margin expansion more difficult than adjusted EBITDA trends imply.

Stevanato Group News

Stevanato Group initiated with a Hold at Deutsche Bank

Deutsche Bank initiated coverage of Stevanato Group (STVN) with a Hold rating and $22 price target The company...

19d ago

STVN

Stevanato Group initiated with a Neutral at UBS

UBS initiated coverage of Stevanato Group (STVN) with a Neutral rating and EUR 23 price target The firm...

2M ago

STVN

Stevanato Group Q2 2026 Results Highlight Shift to High-Value Drug Delivery Systems

Stevanato Group ( ($STVN) ) has provided an announcement. Stevanato Group S.p.A. is an Italy-based provider of drug...

3M ago

STVN

Stevanato Group: Improving Earnings Quality and High-Value Solutions Support Buy Rating and Long-Term Margin Expansion

TD Cowen analyst Chad Wiatrowski maintained a Buy rating on Stevanato Group yesterday and set a price target...

3M ago

STVN

Stevanato Group Q2 2026 Earnings Call Highlights

Stevanato Group Spa (($STVN)) has held its Q2 earnings call. Read on for the main highlights of the...

3M ago

STVN

Stevanato Group Details Mid-2026 Performance and Risk Landscape in Unaudited Interim Report

Stevanato Group ( ($STVN) ) just unveiled an announcement. Stevanato Group has filed an unaudited interim report for...

3M ago

STVN

Stevanato Group Posts 8% Q2 Revenue Growth and Sells U.S. Subsidiary Balda C. Brewer

Stevanato Group ( ($STVN) ) has shared an update. Stevanato Group reported that in the second quarter of...

3M ago

STVN

Stevanato Group Files Form 6-K Detailing Q2 2026 Investor Presentation

Stevanato Group ( ($STVN) ) has issued an update. On August 4, 2026, Stevanato Group filed a Form...

3M ago

STVN

Stevanato Group reports Q2 EPS EUR0.08 vs. EUR0.11 last year

Reports Q2 revenue EUR302.0M vs. EUR280.0M last year. CEO Franco Stevanato commented, “Results were in line with our...

3M ago

STVN

Stevanato Group narrows 2026 adjusted EPS view to EUR0.60-EUR0.62

Narrows 2026 revenue view to EUR1.26B-EUR1.28B from EUR1.26B-EUR1.29B. Published first on TheFly – the ultimate source for real-time,...

3M ago

STVN

Stevanato Group’s Alina pen injector platform authorized in Europe

Stevanato Group (STVN) announced that liraglutide-based combination products incorporating Stevanato Group’s proprietary Alina pen injector platform have received...

3M ago

STVN

Stevanato Group initiated with a Buy at TD Cowen

TD Cowen initiated coverage of Stevanato Group (STVN) with a Buy rating and $25 price target The firm...

4M ago

STVN

Stevanato Group Shareholders Approve 2025 Accounts, Dividend and Governance Changes

The latest update is out from Stevanato Group ( ($STVN) ). Stevanato Group held its Ordinary and Extraordinary...

5M ago

STVN

Stevanato Group assumed with an Outperform at Wolfe Research

Wolfe Research assumed coverage of Stevanato Group (STVN) with an Outperform rating and $21 price target The firm...

5M ago

STVN

87N FAQ

What was Stevanato Group’s price range in the past 12 months?

Stevanato Group lowest stock price was €11.30 and its highest was €23.60 in the past 12 months.

What is Stevanato Group’s market cap?

Stevanato Group’s market cap is €4.74B.

When is Stevanato Group’s upcoming earnings report date?

Stevanato Group’s upcoming earnings report date is Nov 03, 2026 which is in 8 days.

How were Stevanato Group’s earnings last quarter?

Stevanato Group released its earnings results on Aug 04, 2026. The company reported €0.14 earnings per share for the quarter, beating the consensus estimate of €0.127 by €0.013.

Is Stevanato Group overvalued?

According to Wall Street analysts Stevanato Group’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Stevanato Group pay dividends?

Stevanato Group does not currently pay dividends.

What is Stevanato Group’s EPS estimate?

Stevanato Group’s EPS estimate is 0.16.

How many shares outstanding does Stevanato Group have?

Stevanato Group has 49,709,717 shares outstanding.

What happened to Stevanato Group’s price movement after its last earnings report?

Stevanato Group reported an EPS of €0.14 in its last earnings report, beating expectations of €0.127. Following the earnings report the stock price went down -4.494%.

Which hedge fund is a major shareholder of Stevanato Group?

Currently, no hedge funds are holding shares in DE:87N

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Stevanato Group Stock Smart Score

Neutral

Fundamentals

Return on Equity

8.94%

Trailing 12-Months

Asset Growth

8.48%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Stevanato Group

Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.

Stevanato Group (87N) Earnings & Revenues

Historic Earnings Reports

87N Company Deck

87N Earnings Call

Q2 2026

0:00 / 0:00

Earnings Call Sentiment|Positive

The call presented a generally constructive operational and commercial story: top-line growth (8% y/y), strong expansion of high-value solutions (+16%) and significant adjusted EBITDA and margin improvement. The company announced an important commercial milestone (Alina approvals) and ongoing capacity build-outs that support mid- to long-term value capture in biologics. Offsetting these positives were one-time divestiture costs (EUR 12.2m), negative free cash flow in the quarter, elevated net debt, higher taxes, and caution around elongated sales cycles in Engineering. On balance, the highlights — recurring revenue growth, margin expansion, product approvals and clear capacity investments — outweigh the near-term lowlights tied largely to one-time items and measured execution/timing risks.View all DE:87N earnings summaries

87N Stock 12 Month Forecast

Average Price Target

€20.71

▲(13.79% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"€10","17":"€17","24":"€24","13.5":"€13.5","20.5":"€20.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":23.20943664,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€23.21</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":20.709958848,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€20.71</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17.8534128,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€17.85</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,13.5,17,20.5,24],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.6,18.031495126153846,18.462990252307694,18.89448537846154,19.325980504615387,19.757475630769232,20.188970756923077,20.620465883076925,21.05196100923077,21.483456135384614,21.914951261538462,22.346446387692307,22.777941513846155,{"y":23.20943664,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.6,17.839227603692308,18.078455207384618,18.317682811076924,18.55691041476923,18.79613801846154,19.035365622153847,19.274593225846154,19.51382082953846,19.75304843323077,19.992276036923077,20.231503640615383,20.470731244307693,{"y":20.709958848,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.6,17.619493292307695,17.638986584615385,17.658479876923078,17.67797316923077,17.69746646153846,17.716959753846155,17.736453046153848,17.75594633846154,17.77543963076923,17.794932923076924,17.814426215384618,17.833919507692308,{"y":17.8534128,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.12,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.522,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.23,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.337,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.052,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.753,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.757,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.248,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.942,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.2,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.8,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.6,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >